Jennifer Horrigan
director
oncology
Breast Cancer Trials
New Zealand
Biography
Jennifer Horrigan was appointed to the Breast Cancer Trials Board of Directors in October 2015 and is the Chair of the Communications and Fundraising Committee and a member of the Finance and Audit Committee. She has more than 25 years’ experience across investment banking, financial communication, investor relations and strategic communications. She has extensive experience in enterprise management, including the supervision and management of compliance, financial management and reporting, HR and other critical administrative areas. Ms Horrigan is also a director of Redkite; QV Equities (ASX: QVE); APN Funds Management; Generation Healthcare (ASX: GHC) and Industria REIT (ASX: IDR). Her qualifications include a Bachelor of Business (QUT), Graduate Diploma in Applied Finance (Finsia), Graduate Diploma in Management (AGSM) and she is a member of the Australian Institute of Company Directors (MAICD).
Research Interest
Jennifer Horrigan was appointed to the Breast Cancer Trials Board of Directors in October 2015 and is the Chair of the Communications and Fundraising Committee and a member of the Finance and Audit Committee. She has more than 25 years’ experience across investment banking, financial communication, investor relations and strategic communications. She has extensive experience in enterprise management, including the supervision and management of compliance, financial management and reporting, HR and other critical administrative areas. Ms Horrigan is also a director of Redkite; QV Equities (ASX: QVE); APN Funds Management; Generation Healthcare (ASX: GHC) and Industria REIT (ASX: IDR). Her qualifications include a Bachelor of Business (QUT), Graduate Diploma in Applied Finance (Finsia), Graduate Diploma in Management (AGSM) and she is a member of the Australian Institute of Company Directors (MAICD).
